Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,915Revenue (TTM) $M3,842Net Margin (%)-3.3Altman Z-Score0.1
Enterprise Value $M10,649EPS (TTM) $-0.3Operating Margin %-9.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-22.7Higher ROA y-yY
Price/Book0.510-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %--Current Ratio0.8Lower Leverage y-yY
Price/Free Cash Flow5.6y-y EBITDA Growth Rate %--ROA % (ttm)-0.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-2.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M223ROIC % (ttm)2.0Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ENDP is held by these investors:



ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIMMEL ROGER HDirector 2016-11-15Sell14,000$17.38-24.74view
HIGGINS ARTHUR JDirector 2016-05-11Buy5,000$13.8-5.22view
KIMMEL ROGER HDirector 2016-05-10Buy7,000$15.53-15.78view
HIGGINS ARTHUR JDirector 2016-05-10Buy11,000$15.42-15.18view
Campanelli PaulGroup President, Generics 2016-05-10Buy13,000$15.53-15.78view
INGRAM DOUGLAS SDirector 2016-05-05Sell4,513$26.59-50.81view
Spengler WilliamDirector 2016-03-17Buy1,000$29.2-55.21view
Spengler WilliamDirector 2016-03-16Buy1,000$35.24-62.88view
KIMMEL ROGER HDirector 2016-03-14Buy1,125$41.94-68.81view
Maletta Matthew JosephExec. V.P.,Chief Legal Officer 2016-03-07Buy500$44.48-70.59view

Quarterly/Annual Reports about ENDP:

News about ENDP:

Articles On GuruFocus.com
Weitz Funds Comments on Endo International Jan 26 2017 
4 Stocks Reach Their 3-Year Lows Jan 21 2017 
Wally Weitz Comments on Endo Nov 08 2016 
Wally Weitz's Partners Value Fund 3rd Quarter Commentary Nov 08 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
US Market Indexes Reach New Highs Aug 09 2016 
Weitz Funds Comments on Endo International Jul 20 2016 
Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary Jul 20 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 

More From Other Websites
Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results Feb 13 2017
Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results Feb 13 2017
Is More Downside Ahead For Teva Pharmaceutical? Feb 10 2017
Canada's TMX seeks part of Saudi Aramco listing Feb 08 2017
Canada's TMX seeks part of Saudi Aramco listing Feb 08 2017
Belbuca return expected to push BDSI to profitability sooner Feb 01 2017
Endo's (ENDP) Ephedrine Sulfate Injection Gets FDA Approval Jan 31 2017
Endo International: We Believe? Jan 31 2017
Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP Jan 30 2017
Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP Jan 30 2017
Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised) Jan 30 2017
Endo (ENDP) Restructures its Branded Pharmaceutical Unit Jan 27 2017
New Strong Sell Stocks for January 27th Jan 27 2017
Weitz Funds Comments on Endo International Jan 26 2017
Endo to cut 90 jobs as part of drugmaker's restructuring Jan 26 2017
ENDO INTERNATIONAL PLC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities,... Jan 26 2017
Endo Announces Actions to Drive Greater Efficiency and Business Alignment Jan 26 2017
Endo Announces Actions to Drive Greater Efficiency and Business Alignment Jan 26 2017
Endo Settles FTC 'Pay-for-Delay' Allegations Jan 25 2017
Endo (ENDP) Settles Disputes with Federal Trade Commission Jan 24 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)